Literature DB >> 21392861

Quinolino-benzo-[5, 6]-dihydroisoquindolium compounds derived from berberine: a new class of highly selective ligands for G-quadruplex DNA in c-myc oncogene.

Yan Ma1, Tian-Miao Ou, Jia-Heng Tan, Jin-Qiang Hou, Shi-Liang Huang, Lian-Quan Gu, Zhi-Shu Huang.   

Abstract

A series of quinolino-benzo-[5, 6]-dihydroisoquindolium compounds (3a, 3f, 3g, and 3j) derived from alkaloid berberine were designed and synthesized as novel G-quadruplex ligands. Subsequent biophysical and biochemical evaluation demonstrated that the addition of pyridine ring and amino group into berberine improved the binding ability and selectivity towards G-quadruplex DNA in comparison with the previously reported 9-N-substituted berberine derivatives. Furthermore, qRT-PCR assay showed compound 3j led the down-regulation of c-myc gene transcription in leukemia cell line HL60, while little effect on normal cell line ECV-304, which was consistent with the behavior of an effective G-quadruplex ligand targeting c-myc oncogene.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392861     DOI: 10.1016/j.ejmech.2011.02.020

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  Platinum(ii) complexes with rutaecarpine and tryptanthrin derivatives induce apoptosis by inhibiting telomerase activity and disrupting mitochondrial function.

Authors:  Qi-Pin Qin; Bi-Qun Zou; Fei-Long Hu; Guo-Bao Huang; Shu-Long Wang; Yun-Qiong Gu; Ming-Xiong Tan
Journal:  Medchemcomm       Date:  2018-08-08       Impact factor: 3.597

2.  Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.

Authors:  Peda V L Boddupally; Seongmin Hahn; Cristina Beman; Biswanath De; Tracy A Brooks; Vijay Gokhale; Laurence H Hurley
Journal:  J Med Chem       Date:  2012-06-25       Impact factor: 7.446

3.  Chemical intervention of the NM23-H2 transcriptional programme on c-MYC via a novel small molecule.

Authors:  Chan Shan; Jing Lin; Jin-Qiang Hou; Hui-Yun Liu; Shuo-Bin Chen; Ai-Chun Chen; Tian-Miao Ou; Jia-Heng Tan; Ding Li; Lian-Quan Gu; Zhi-Shu Huang
Journal:  Nucleic Acids Res       Date:  2015-06-27       Impact factor: 16.971

4.  Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway.

Authors:  Jianyou Gu; Yu Zhang; Xiao Wang; Jingjing Xiang; Shu Deng; Dijiong Wu; Junfa Chen; Lihong Yu; Yan Zhou; Yaokun Wang; Jianping Shen
Journal:  BMC Complement Med Ther       Date:  2020-07-08

Review 5.  G-quadruplexes: a promising target for cancer therapy.

Authors:  Annkristin Heine; Katrin Paeschke; Nils Kosiol; Stefan Juranek; Peter Brossart
Journal:  Mol Cancer       Date:  2021-02-25       Impact factor: 27.401

6.  Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKIIγ/c-Myc/CDK6 signaling pathway.

Authors:  Jianyou Gu; Xiao Wang; Ling Zhang; Jingjing Xiang; Jingya Li; Zheng Chen; Yu Zhang; Junfa Chen; Jianping Shen
Journal:  BMC Complement Med Ther       Date:  2021-06-04

7.  A DNA small molecular probe with increasing K+ concentration promoted selectivity.

Authors:  Ya-Ping Gong; Jian Yang; Ji-Wang Fang; Qian Li; Zhi-Yong Yu; Aijiao Guan; Han-Yuan Gong
Journal:  RSC Adv       Date:  2021-04-22       Impact factor: 3.361

Review 8.  Structural modifications of berberine and their binding effects towards polymorphic deoxyribonucleic acid structures: A review.

Authors:  Lanlan Fu; Jiajia Mou; Yanru Deng; Xiaoliang Ren
Journal:  Front Pharmacol       Date:  2022-08-09       Impact factor: 5.988

9.  Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine.

Authors:  Vishnu Muthuraj Kumarasamy; Yoon-Joo Shin; John White; Daekyu Sun
Journal:  BMC Cancer       Date:  2015-08-26       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.